These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1992111)

  • 1. Three-dimensional structure-activity relationships and receptor mapping of N1-substituents of quinolone antibacterials.
    Ohta M; Koga H
    J Med Chem; 1991 Jan; 34(1):131-9. PubMed ID: 1992111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and biological activities of new N1-aryl substituted quinolone antibacterials.
    Jürgens J; Schedletzky H; Heisig P; Seydel JK; Wiedemann B; Holzgrabe U
    Arch Pharm (Weinheim); 1996 Apr; 329(4):179-90. PubMed ID: 8669982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
    Bagchi MC; Mills D; Basak SC
    J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the dynamic quantitative structure-activity relationship method for modeling antibacterial activity of quinolone derivatives.
    Kamenska V; Mekenyan O; Sterev A; Nedjalkova Z
    Arzneimittelforschung; 1996 Apr; 46(4):423-8. PubMed ID: 8740092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Aminoquinolones: a new class of quinolone antibacterials?
    Cecchetti V; Clementi S; Cruciani G; Fravolini A; Pagella PG; Savino A; Tabarrini O
    J Med Chem; 1995 Mar; 38(6):973-82. PubMed ID: 7699714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationship model for prediction of genotoxic potential for quinolone antibacterials.
    Hu J; Wang W; Zhu Z; Chang H; Pan F; Lin B
    Environ Sci Technol; 2007 Jul; 41(13):4806-12. PubMed ID: 17695933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of quinolone antibacterial agents: the effects of C-2 substitution.
    Chu DT; Lico IM; Claiborne AK; Plattner JJ; Pernet AG
    Drugs Exp Clin Res; 1990; 16(5):215-24. PubMed ID: 1964116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli.
    Ehrhardt AF; Sanders CC
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2570-2. PubMed ID: 9371371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone antimicrobial agents: structure-activity relationships.
    Zhang MQ; Haemers A
    Pharmazie; 1991 Oct; 46(10):687-700. PubMed ID: 1803382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials.
    Ghosh P; Thanadath M; Bagchi MC
    Mol Divers; 2006 Aug; 10(3):415-27. PubMed ID: 16896544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional quantitative structure-activity relationship (3D-QSAR) of 3-aryloxazolidin-2-one antibacterials.
    Karki RG; Kulkarni VM
    Bioorg Med Chem; 2001 Dec; 9(12):3153-60. PubMed ID: 11711290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone antibacterials containing the new 7-[3-(1-aminoethyl)-1- pyrrolidinyl] side chain: the effects of the 1-aminoethyl moiety and its stereochemical configurations on potency and in vivo efficacy.
    Domagala JM; Hagen SE; Joannides T; Kiely JS; Laborde E; Schroeder MC; Sesnie JA; Shapiro MA; Suto MJ; Vanderroest S
    J Med Chem; 1993 Apr; 36(7):871-82. PubMed ID: 8385225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro and in vivo evaluation of quinolones with selective activity against gram-positive organisms.
    Cooper CS; Klock PL; Chu DT; Hardy DJ; Swanson RN; Plattner JJ
    J Med Chem; 1992 Apr; 35(8):1392-8. PubMed ID: 1573632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent non-6-fluoro-substituted quinolone antibacterials: synthesis and biological activity.
    Ledoussal B; Bouzard D; Coroneos E
    J Med Chem; 1992 Jan; 35(1):198-200. PubMed ID: 1732530
    [No Abstract]   [Full Text] [Related]  

  • 15. Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity.
    Peterson LR
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S180-6. PubMed ID: 11524717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
    Domagala JM; Heifetz CL; Hutt MP; Mich TF; Nichols JB; Solomon M; Worth DF
    J Med Chem; 1988 May; 31(5):991-1001. PubMed ID: 2834557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antibacterial activity of 1-(substituted pyrrolyl)-7-(substituted amino)-6-fluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids.
    Liu JH; Guo HY
    J Med Chem; 1992 Sep; 35(19):3469-73. PubMed ID: 1404228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships in quinolone antibacterials: design, synthesis and biological activities of novel isothiazoloquinolones.
    Chu DT; Fernandes PB; Claiborne AK; Shen L; Pernet AG
    Drugs Exp Clin Res; 1988; 14(6):379-83. PubMed ID: 2850902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of new 7-[3-(fluoromethyl)piperazinyl]- and -(fluorohomopiperazinyl)quinolone antibacterials.
    Ziegler CB; Bitha P; Kuck NA; Fenton TJ; Petersen PJ; Lin YI
    J Med Chem; 1990 Jan; 33(1):142-6. PubMed ID: 2104934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis and in vitro antibacterial activity of conformationally restricted quinolone antibacterial agents.
    Cooper CS; Tufano MD; Donner PK; Chu DT
    Bioorg Med Chem; 1996 Aug; 4(8):1307-15. PubMed ID: 8879552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.